Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Today's Low | Today's High | |
---|---|---|
90.80 90.90 |
| 98.14 99.45 |
52 Week Low | 52 Week High | |
---|---|---|
89.50 (13-Mar-2024) 89.90 (13-Mar-2024) |
| 131.40 (24-Apr-2024) 131.30 (24-Apr-2024) |
Buy Order Quantity | Sell Order Quantity | |
---|---|---|
0 | 0 |
Bid Price | Quantity |
---|---|
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | -- |
Ask Price | Quantity |
---|---|
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | -- |
Market Cap: | 4.53 Cr |
PE Ratio (TTM): | 31.85 |
PB Ratio: | 1.93 |
Industry P/E: | 30.85 |
Debt to Equity: | - |
ROE: | 6.06 |
EPS (TTM): | 2.92 |
Book Value: | 249.65 |
Face Value: | 10.00 |
Mar, 2023 | Jun, 2023 | Dec, 2022 | Mar, 2023 | Dec, 2022 | |
---|---|---|---|---|---|
Revenue | 23.61 Cr | 8.62 Cr | 10.54 Cr | 104.45 Cr | 100.32 Cr |
Profit | 1.63 Cr | 0.22 Cr | 0.24 Cr | 7.14 Cr | 6.57 Cr |
Expense | 21.13 Cr | 8.33 Cr | 10.30 Cr | 95.25 Cr | 92.85 Cr |
Comprehensive income | 1.63 Cr | 0.25 Cr | 0.24 Cr | 6.64 Cr | 6.58 Cr |
EPS | 1.50 | 1.50 | 0.22 | 1.46 | 1.35 |
Company name | Listing date | Industry | NSE symbol BSE symbol |
---|---|---|---|
Zim Laboratories Limited | Nov, 2022 Jun, 2018 | Pharmaceuticals Pharmaceuticals | ZIMLAB ZIMLAB |
Promoters | |
---|---|
33.26% |
Public | |
---|---|
66.74% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
33.26% |
Public | |
---|---|
66.74% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
33.26% |
Public | |
---|---|
66.74% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
33.26% |
Public | |
---|---|
66.74% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
33.26% |
Public | |
---|---|
66.74% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Today's stock performance witnessed a fluctuation from a minimum of 90.80 on the NSE (National Stock Exchange) to a maximum of 98.14. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 90.90 to a high of 99.45.
The stock's performance over the past 52 weeks reveals a low of 89.50 (occurred on 13-Mar-2024) and a high of 131.40 (achieved on 24-Apr-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 89.90 (on 13-Mar-2024), and the 52-week high is 131.30 (on 24-Apr-2024).
The stock's performance over the past 52 weeks reveals a low of 89.50 (occurred on 13-Mar-2024) and a high of 131.40 (achieved on 24-Apr-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 89.90 (on 13-Mar-2024), and the 52-week high is 131.30 (on 24-Apr-2024).
The total volume is 2, and the total traded value is 1.41 ( Lakhs).
The upper circuit limit is 116.73, and the lower circuit limit is 77.82.
The market cap is 4.53 Cr, and the PE ratio (TTM) is 30.85.
The PB ratio is 0.37, industry P/E is 30.85 .
ROE is 6.06, EPS is 2.92, book value is 249.65
In Mar 2023, Revenue is 236126000.00, and Profit is 16288000.00. In Jun 2023, Revenue is 86198000.00, and Profit is 2239000.00.
The company, Zim Laboratories Limited, was listed in Nov 2022 and belongs to the Pharmaceuticals industry. Its NSE symbol is ZIMLAB.
As of latest available update, promoters hold 33.26%, the public holds 66.74%, and Employee Trusts holds 0.00.
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.